Inspirata, Inc news
Inspirata Inc. and FUJIFILM Corporation signed an asset purchase agreement for Fujifilm to acquire Inspirata’s Dynamyx® digital pathology technology, employees and customers, building off the proven success of the established partnership between the companies in UK and Europe. This milestone allows the Digital Pathology business to flourish with a partner who has the breadth, depth and resources required to take the Dynamyx platform to the next stage of its grow
Oncology informatics company, Inspirata, is pleased to announce the recent addition of a new key member to the company’s leadership team. Effective November 17, 2022, Laure Tessier-Delivuk, PMP, has joined as Vice President of Operations – Oncology Informatics.
Laure brings 25+ years of experience as a Healthcare Technology executive leader and a proven track record in managing multimillion-dollar business units to achieve revenue, profit, and growth objectives. Her primar
Oncology informatics company, Inspirata, is pleased to announce the recent addition of a new key member to the company’s leadership team. Effective October 3rd, 2022, Laurie Smith has joined as Vice President of Product Strategy – Clinical Trial Matching.
Laurie will be primarily focused on enhancing Inspirata’s suite of clinical trial matching solutions. This includes com
Digital pathology and cancer informatics provider Inspirata is proud to announce a new partnership with precision pathology company SpIntellx, further strengthening and diversifying Inspirata’s growing partner ecosystem.
This partnership allows Inspirata and SpIntellx customers the seamless integration of Dynamyx </
Cancer informatics provider Inspirata announced today that it has become a member of the Advarra Partner Program. As an inaugural API Gold partner, Inspirata will collaborate closely with Advarra’s engineering and support teams on ensuring out-of-the-box integrations between OnCore, an Advarra CTMS solution, and Trial Navigator, Inspirata’s fully automated, NLP-powered clinical